No

Corticosteroid, Topical

Inflammation of corticosteroid-responsive dermatoses [medium potency topical corticosteroid]

C

Viral, fungal, or tubercular skin lesions, known hypersensitivity to flurandrenolide

Adverse systemic effects may occur when used on large areas of the body, denuded areas, for prolonged periods of time, with an occlusive dressing, and/or in infants or small children

<1%: Itching, dry skin, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, skin atrophy, striae, miliaria, intracranial hypertension, acne, maceration of the skin; HPA suppression, Cushing's syndrome, growth retardation, burning, irritation, secondary infection

When consumed in excessive quantities, systemic hypercorticism and adrenal suppression may occur; in those cases, discontinuation and withdrawal of the corticosteroid should be done judiciously

No data reported

Decreases inflammation by suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability

Absorption: Adequate with intact skin

Metabolism: In the liver

Elimination: By the kidney with small amounts appearing in bile

Repeated applications lead to depot effects on skin, potentially resulting in enhanced percutaneous absorption

Topical: Therapy should be discontinued when control is achieved; if no improvement is seen, reassessment of diagnosis may be necessary.

Ointment, cream: Apply sparingly 1-2 times/day

Tape: Apply once daily

Adults: Cream, lotion, ointment: Apply sparingly 2-3 times/day

No information available to require special precautions

No effects or complications reported

A thin film of cream or ointment is effective; do not overuse; do not use tight-fitting diapers or plastic pants on children being treated in the diaper area; use only as prescribed, and for no longer than the period prescribed; apply sparingly in light film; rub in lightly; avoid contact with eyes; notify physician if condition being treated persists or worsens

A thin film of cream or ointment is effective; do not overuse; do not use tight-fitting diapers or plastic pants on children being treated in the diaper area; use only as prescribed, and for no longer than the period prescribed; apply sparingly in light film; rub in lightly; avoid contact with eyes; notify physician if condition being treated persists or worsens

Cream, emulsified base (Cordran® SP): 0.025% (30 g, 60 g); 0.05% (15 g, 30 g, 60 g)

Lotion (Cordran®): 0.05% (15 mL, 60 mL)

Ointment, topical (Cordran®): 0.025% (30 g, 60 g); 0.05% (15 g, 30 g, 60 g)

Tape, topical (Cordran®): 4 mcg/cm² (7.5 cm x 60 cm, 7.5 cm x 200 cm rolls)